Hard and soft nanoparticles for image-guided surgery in nanomedicine
Source abstract
Abstract
The use of hard and/or soft nanoparticles for therapy, collectively called nanomedicine, has great potential in the battle against cancer. Major research efforts are underway in this area leading to development of new drug delivery approaches and imaging techniques. Despite this progress, the vast majority of patients who are affected by cancer today sadly still need surgical intervention, especially in the case of solid tumors. An important perspective for researchers is therefore to provide even more powerful tools to the surgeon for pre- and post-operative approaches. In this context, image-guided surgery, in combination with nanotechnology, opens a new strategy to win this battle. In this perspective, we will analyze and discuss the recent progress with nanoparticles of both metallic and biomaterial composition, and their use to develop powerful systems to be applied in image-guided surgery.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics · Gold and Silver Nanoparticles Synthesis and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (21)
Show source-provided references
1. Barone DG, Lawrie T, Hart MG (2014) Image guided surgery for the resection of brain tumours. Cochrane Database of Syst Rev 1:CD009685
2. Benezra M, Penate-Medina O, Zanzonico PB, Schaer D, Ow H, Burns A, DeStanchina E, Longo V, Herz E, Iyer S, Wolchok J, Larson SM, Wiesner U, Bradbury MS (2011) Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma. J Clin Investig 121(7):276810.1172/JCI45600 ↗
3. Bradbury MS, Phillips E, Montero PH, Cheal SM, Stambuk H, Durack JC, Sofocleous TC, Meester RJC, Wiesnerw U, Patel S (2013) Clinically-translated silica nanoparticles as dual-modality cancer-targeted probes for image-guided surgery and interventions. Integr Biol 5(1):74–8610.1039/C2IB20174G ↗
4. Burns AA, Vider J, Ow H, Herz E, Penate-Medina O, Baumgart M, Larson SM, Wiesner U, Bradbury M (2008) Fluorescent silica nanoparticles with efficient urinary excretion for nanomedicine. Nano Lett 9(1):442–44810.1021/nl803405h ↗
5. Cho H, Cho CS, Indig GL, Lavasanifar A, Vakili MR, Kwon GS (2014) Polymeric micelles for apoptosis-targeted optical imaging of cancer and intraoperative surgical guidance. PLoS ONE 9(2):e8996810.1371/journal.pone.0089968 ↗
6. Frost & Sullivan (2007) North American Contrast Media Markets; Pub ID: MC1521546
7. Hill TK, Abdulahad A, Kelkar SS, Marini FC, Long TE, Provenzale JM, Mohs AM (2015) Indocyanine green-loaded nanoparticles for image-guided tumor surgery. Bioconjugate Chem 26:294–30310.1021/bc5005679 ↗
8. Josephson L, Tung CH, Moore A, Weissleder R (1999) High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. Bioconjug. Chem 10:186–19110.1021/bc980125h ↗
9. Keereweer S, Kerrebijn JD, Van Driel PB, Xie B, Kaijzel EL, Snoeks TJ, Que I, Hutteman M, van der Vorst JR, Mieog JSD, Vahrmeijer AL, van de Velde CJH, de Jong RJB, Löwik CW (2011) Optical image-guided surgery—where do we stand? Mol Imag Biol 13(2):199–20710.1007/s11307-010-0373-2 ↗
10. Kircher MF, Mahmood U, King RS, Weissleder R, Josephson L (2003) A multimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineation. Cancer Res 63(23):8122–8125
11. Kircher MF, de la Zerda A, Jokerst JV, Zavaleta CL, Kempen PJ, Mittra E, Pitter K, Huang R, Campos C, Habte F, Sinclair R, Brennan CW, Mellinghoff IK, Holland EC, Gambhir SS (2012) A brain tumor molecular imaging strategy using a new triple-modality MRI-photoacoustic-Raman nanoparticle. Nat Med 18(5):829–83410.1038/nm.2721 ↗
12. Li Y, Li Z, Wang X, Liu F, Cheng Y, Zhang B, Shi D (2012) In vivo cancer targeting and imaging-guided surgery with near infrared-emitting quantum dot bioconjugates. Theranostics 2(8):769–77610.7150/thno.4690 ↗
13. Noorlander CW, Kooi MW, Oomen AG, Park MVDZ, Vandebriel RJ, Geertsma RE (2015) Horizon scan of nanomedicinal products. Nanomedicine 10(10):1599–160810.2217/nnm.15.21 ↗
14. Phillips E, Penate-Medina O, Zanzonico PB, Carvajal RD, Mohan P, Ye Y, Humm J, Gönen M, Kalaigian H, Schöder H, Strauss HW, Larson SM, Wiesner U, Bradbury MS (2014) Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe. Sci Transl Med 6(260):260ra14910.1126/scitranslmed.3009524 ↗
15. Rizzo LY, Theek B, Storm G, Kiessling F, Lammers T (2013) Recent progress in nanomedicine: therapeutic, diagnostic and theranostic applications. Curr Opin Biotechnol 24(6):1159–116610.1016/j.copbio.2013.02.020 ↗
16. Schaafsma BE, Mieog JSD, Hutteman M, Van der Vorst JR, Kuppen PJ, Löwik CW, Frangioni JV, van de Velde CJH, Vahrmeijer AL (2011) The clinical use of indocyanine green as a near-infrared fluorescent contrast agent for image-guided oncologic surgery. J Surg Oncol 104(3):323–33210.1002/jso.21943 ↗
17. Tanaka E, Choi HS, Fujii H, Bawendi MG, Frangioni JV (2006) Image-guided oncologic surgery using invisible light: completed pre-clinical development for sentinel lymph node mapping. Ann Surg Oncol 13(12):1671–168110.1245/s10434-006-9194-6 ↗
18. TechNavio (Infiniti Research Ltd.) (2015) Global Contrast media/contrast agents market 2015–2019
19. Xi L, Zhou G, Gao N, Yang L, Gonzalo DA, Hughes SJ, Jiang H (2014) Photoacoustic and fluorescence image-guided surgery using a multifunctional targeted nanoprobe. Ann Surg Oncol 21:1602–160910.1245/s10434-014-3541-9 ↗
20. Xiong C, Brewer K, Song S, Zhang R, Lu W, Wen X, Li C (2011) Peptide-based imaging agents targeting phosphatidylserine for the detection of apoptosis. J Med Chem 54:1825–183510.1021/jm101477d ↗
21. Xu X, Ho W, Zhang X, Bertrand N, Farokhzad O (2015) Cancer nanomedicine: from targeted delivery to combination therapy. Trends Mol Med 21(4):223–23210.1016/j.molmed.2015.01.001 ↗